Poland· PL-100418676

Fingolimod MSN

A fingolimod product containing fingolimodum, registered in Poland by MSN Labs Europe Limited. The same ATC class is registered in 3 of our 19 countries.

ATC L04AA27

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedFingolimod MSNATCL04AA27REGISTER NO.PL-100418676PACKS LISTED24CHECKEDSeptember 27, 2026

Where it is registered

Fingolimod is registered in 3 of 19 countries.

Countries holding a registration under ATC L04AA27 (fingolimod), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Fingolimod · ATC L04AA27

3 / 19 countries

  • Belgiumprice
  • Ireland
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Fingolimodum
Manufacturer
MSN Labs Europe Limited
Country
Poland (PL)
ATC code
L04AA27
ATC class
Fingolimod
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 24

  • gtin
    05909991450533
  • gtin
    05909991450540
  • gtin
    05909991450557
  • gtin
    05909991450564
  • gtin
    05909991450571
  • gtin
    05909991450588
  • gtin
    05909991450595
  • gtin
    05909991450601
  • gtin
    05909991450618
  • gtin
    05909991450625
  • gtin
    05909991450632
  • gtin
    05909991450649
  • gtin
    05909991450656
  • gtin
    05909991450663
  • gtin
    05909991450670
  • gtin
    05909991450687
  • gtin
    05909991450694
  • gtin
    05909991450700
  • gtin
    05909991450717
  • gtin
    05909991450724
  • gtin
    05909991450731
  • gtin
    05909991450748
  • gtin
    05909991450755
  • gtin
    05909991450762

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

584 interactions on record for fingolimod.

Graded by severity as the source publishes them — 503 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Fingolimod · interactions on record

584 records

  • 503 severe
  • 77 moderate
  • 4 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fingolimod in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fingolimod products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Areleptan, Chantico
  • Belgium · Fingolimod Ab, Fingolimod Eg
  • Bulgaria · Chantico, Inzolfi
  • Cyprus · Fingolimod Adelco, Fingolimod Remedica
  • Czechia · Areleptan, Bonaxon
  • Germany · Fingod, Fingolimod 123 Acurae Pharma
  • Denmark · Areleptan, Bonaxon
  • Estonia · Chantico, Efigalo
  • Spain · Fingolimod, Fingolimod Aurovitas
  • Finland · Fingolimod, Fingolimod Avansor
  • France · Fingolimod Arrow, Fingolimod Benta
  • United Kingdom (Northern Ireland) · Fingolimod, Fingolimod Amarox
  • Greece · Fingolimod Adelco, Fingolimod Medochemie
  • Croatia · Areleptan, Arlesias
  • Hungary · Bonaxon, Chantico
  • Ireland · Fingolimod Clonmel, Fingolimod Flynn Pharma
  • Iceland · Fingolimod, Fingolimod Accord
  • Italy · Fingolimod Aurobindo, Fingolimod Dr. Reddy’s
  • Liechtenstein · Fingolimod Accord, Fingolimod Mylan
  • Lithuania · Chantico, Efigalo
  • Luxembourg · Fingolimod Eg, Fingolimod Ratiopharm
  • Latvia · Bonaxon, Chantico
  • Malta · Fingolimod Denk, Fingolimod Remedica
  • Netherlands · Chantico, Fenoxa
  • Norway · Areleptan, Fingolimod Accord
  • Portugal · Bluesar, Fingolimod Bluefish
  • Romania · Fingolimod Dr. Reddys, Fingolimod Msn
  • Sweden · Areleptan, Fingolimod Amarox
  • Slovenia · Areleptan, Arlesias
  • Slovakia · Areleptan, Bonaxon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7dd1365d-8dc9-4277-9339-69bf6a38e057
GET /v1/drugs/7dd1365d-8dc9-4277-9339-69bf6a38e057?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "0,5 mg",
  "packaging": "05909991450533 ¦ Rpz ¦ Skasowane ¦ 139655\n7 kaps. w blistrze perforowanym\n05909991450540 ¦ Rpz ¦ Skasowane ¦ 139656\n7 kaps. w blistrze\n05909991450557 ¦ Rpz ¦ Skasowane ¦ 139657\n10 kaps. w blistrze perforowanym\n05909991450564 ¦ Rpz ¦ Skasowane ¦ 139658\n10 kaps. w blistrze\n05909991450571 ¦ Rpz ¦ Skasowane ¦ 139659\n14 kaps. w blistrze\n05909991450588 ¦ Rpz ¦ Skasowane ¦ 139660\n14 kaps. w blistrze perforowanym\n05909991450595 ¦ Rpz ¦ Skasowane ¦ 139661\n28 kaps. w blistrze perforowanym\n05909991450601 ¦ Rpz ¦ Skasowane ¦ 139662\n28 kaps. w blistrze\n05909991450618 ¦ Rpz ¦ Skasowane ¦ 139663\n30 kaps. w blistrze\n05909991450625 ¦ Rpz ¦ Skasowane ¦ 139664\n30 kaps. w blistrze perforowanym\n05909991450632 ¦ Rpz ¦ Skasowane ¦ 139665\n98 kaps. w blistrze perforowanym\n05909991450649 ¦ Rpz ¦ Skasowane ¦ 139666\n98 kaps. w blistrze\n05909991450656 ¦ Rpz ¦ 139667\n7 kaps. w blistrze\n05909991450663 ¦ Rpz ¦ 139668\n10 kaps. w blistrze\n05909991450670 ¦ Rpz ¦ 139669\n14 kaps. w blistrze\n05909991450687 ¦ Rpz ¦ 139670\n28 kaps. w blistrze\n05909991450694 ¦ Rpz ¦ 139671\n30 kaps. w blistrze\n05909991450700 ¦ Rpz ¦ 139672\n98 kaps. w blistrze\n05909991450717 ¦ Rpz ¦ 139673\n7 kaps. w blistrze perforowanym\n05909991450724 ¦ Rpz ¦ 139674\n10 kaps. w blistrze perforowanym\n05909991450731 ¦ Rpz ¦ 139675\n14 kaps. w blistrze perforowanym\n05909991450748 ¦ Rpz ¦ 139676\n28 kaps. w blistrze perforowanym\n05909991450755 ¦ Rpz ¦ 139677\n30 kaps. w blistrze perforowanym\n05909991450762 ¦ Rpz ¦ 139678\n98 kaps. w blistrze perforowanym",
  "substance": "Fingolimodum 0.5 mg",
  "common_name": "Fingolimodum",
  "pl_product_id": "100418676",
  "pozwolenie_nr": "26328",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about fingolimod.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.